OH SB309

Health care providers must give pregnant women written information about complications associated with mifepristone (RU-486) and a state-mandated statement informing them of their right to hold manufacturers, distributors, providers, and facilities financially accountable for death, injury, or complications

Pregnant women must certify in writing they received and reviewed the required information before being prescribed the abortion-inducing drug, with providers required to retain certification for at least 7 years (or 5 years after a minor reaches majority, whichever is longer)

Civil liability is established allowing the woman, her spouse, maternal grandparents (if she was a minor or died), or next of kin (if she died) to sue providers who fail to meet disclosure requirements, with damages including injury compensation plus three times the drug's cost

Attorney general or prosecutors may assess civil penalties of up to $5,000 per day of violation, with an additional $10,000 penalty for knowing violations; collected penalties fund crisis pregnancy centers meeting specific statutory criteria

Ohio Department of Health must create a standardized form for providers to use for the required disclosures and certification; women prescribed the drug are explicitly exempt from liability